Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis-Reference-Cited by-同舟云学术

Treatment with the novel TAAR1 agonist ulotaront is associated with reductions in quantitative polysomnographic REM sleep without atonia in healthy human subjects: Results of a post-hoc analysis

Published:2023-01 Issue: Volume:101 Page:578-586
ISSN:1389-9457
Container-title:Sleep Medicine
language:en
Short-container-title:Sleep Medicine

Author:

Feemster John C.,Westerland Sarah M.,Gossard Thomas R.,Steele Tyler A.,Timm Paul C.,Jagielski Jack T.,Strainis Emma,McCarter Stuart J.,Hopkins Seth C.,Koblan Kenneth S.,St. Louis Erik K.

Publisher

Elsevier BV

Subject

General Medicine

Reference42 articles.

1. REM sleep behavior disorder; diagnosis, clinical implications, and future directions;St. Louis;Mayo Clin Proc,2017

2. REM sleep behavior disorder in Parkinson's disease and other synucleinopathies;St. Louis;Mov Disord,2017

3. REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions;Boeve;Ann N Y Acad Sci,2010

4. Chronic behavioral disorders of human REM sleep: a new category of parasomnia;Schenck;Sleep,1986

5. Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series;Schenck;Sleep Med,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O uso de agonistas TAAR1 para o tratamento de Esquizofrenia;Cuadernos de Educación y Desarrollo;2024-01-12

2. TAAR1 as an emerging target for the treatment of psychiatric disorders;Pharmacology & Therapeutics;2024-01

3. Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders;Biomedicines;2023-07-13

4. Canonical and Non-Canonical Antipsychotics’ Dopamine-Related Mechanisms of Present and Next Generation Molecules: A Systematic Review on Translational Highlights for Treatment Response and Treatment-Resistant Schizophrenia;International Journal of Molecular Sciences;2023-03-21

5. Protein Metabolism Changes and Alterations in Behavior of Trace Amine-Associated Receptor 1 Knockout Mice Fed a High-Fructose Diet;Neurology International;2023-02-28